CD8A and neoplasm: Tumor-infiltrating lymphocytes (TILs), particularly the immunoscore comprised of CD3+ and CD8+ T cells, emerge as key contributors to the anti-tumor immune response, demonstrating prognostic significance surpassing that of the conventional American Joint Committee on Cancer (AJCC) and Union for International Cancer Control tumor–node–metastasis (TNM) classification system in CRC3.